Læknablaðið : fylgirit - 01.05.1978, Qupperneq 46

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 46
J. Haapasaari, A-L. Makelá, M. Lempiáinen and T. Yrjana. Departments of Paediatrics and Clinical Chemistry, Turku University Hospital, Turku, Finland. The liquid form of benorylate makes it easy to dosage this drug accurately for children in milligrams per kg of body weight. A harmful handicap is, however, the taste of benorylate mixture, which by some children is considered to be bad and disgusting. This is, however, not a rule, in general children take the mixture quite readily. Conceming the dosage of benorylate to children, in an earlier report from 1974, doctors Powell and Ansell1) recommend benorylate to be started with a dosage of 200 mg/kg/day in cases of juvenile rheumatoid arthritis. According to Powell and Anseil, the blood salicylate level should be checked at seven days during the treat- ment, and the dosage of benorylate should be adjusted to give blood salicylate levels between 25 and 30 mg/100 ml corresponding values 1800- 2300 umol/1. Once a satisfactory blood salicylate level of between 25 and 30 mg/100 ml has been achieved, this dosage should be maintained with an occa- sional monitoring of the salicylate level. This recommended daily dosage of 200 mg/kg of body weight was used also in our study, the BENORYLATE IN THE TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS total daily dose did not, however, exceed 8grams. The purpose of our study was concentrated on clarifying the serumlevels of salicylate and paracetamol achieved with a constant dosage of 200 mg/kg/day of benorylate to children with JRA. In addition, the clinical effect of this constant dosage of benorylate was registered in these children, as well as the possible side-effects. The duration of the test was two weeks. During this period, the serum levels of both salicylates and paracetamol were controlled frequently to investigate their connection to the possible side effects. Twenty-two inpatients, 10 boys and 12 girls, suffering from active juvenile rheumatoid arthri- tis were included this trial. The age of the children ranged between 18 months and 13years. Benorylate was administered twice daily, the total daily dose being 200 mg/kg of body weight. In two cases, in which the weight of the children was more than 40 kg, the total daily dose of benorylate was 8 grams. Salicylate serum levels were estimated spectrophotometrically by Trinder's method. Figure 1. With a constant dosage of benorylate SALICYLATE IN SERUM fjmol/l mg/IOOml 2000 IS00 '600 U.00 '200 '000 aoo 600 400 200 SALICYLATE SERUM CONCENTRATION (MEAN : DOSAGE OF BENORYLATE 200 mg/kg/day S 0) Fig. 1. Salicylate serum levels in children treated with benorylate with a constan daily dose 200 mg/kg during fourteen days. I 2 3 4 5 1 6 7 8 9 10 il 12 13 14 DAYS OF AÐMINISTRATION NUMBER OF 20,SAMPLES 1 ’ 6 ■ 7 ' 8 9 ’ 10 ii ' 12 ' 13 14 DAYS OF ADMINISTRATION 44
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.